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Effects of high glucose on cellular proliferation and fibronectin produc.
tion by cultured human mesangial cells. Diabetic glomerulosclerosis is
characterized by the accumulation of the matrix protein fibronectin in
the glomerular mesangium and could result from increased mesangial
cell fibroneetin synthesis induced by hyperglycemia. To test this
hypothesis, we cultured human mesangial cells for up to 14 days in
media containing normal (5 mM) or high glucose (20 to 115 mM)
concentrations and assessed cellular proliferation and fibronectin syn-
thesis. When compared to 5 m glucose, high glucose levels signifi-
cantly inhibited cellular proliferation in a dose dependent fashion, as
assessed by direct cell counting and thymidine incorporation. After
eight days in culture, tissue culture supernatant fibronectin levels, as
assessed by ELISA, were significantly higher from cells cultured under
high glucose conditions than cells exposed to normal glucose levels.
After 14 days and when compared to 5 mat glucose, matrix fibronectin
levels and fibronectin mRNA expression (by Northern analysis) were
also increased by 20 mat glucose. To control for the osmotic effects of
high glucose, mesangial cells were also cultured in the presence of 20
m or 50 mM mannitol. Mannitol had no effect on cellular proliferation
but significantly increased tissue culture supernatant fibronectin levels
and fibronectin gene expression. These studies demonstrate that, in
vitro, high glucose suppresses human mesangial cell proliferation and
stimulates fibronectin synthesis. The increase in tibronectin synthesis
may in part result from changes in osmolality induced by high glucose.
These data suggest that increased mesangial cell fibronectin synthesis
may play a role in the accumulation of glomerular fibronectin common
to diabetic glomerulosclerosis.
Diabetic glomeruloscierosis is characterized by the accumu-
lation of extracellular matrix proteins in the mesangium [1].
Previous studies have demonstrated that mesangial matrix
expansion occurs early in diabetes and that the degree of matrix
expansion correlates with the severity of the disease [1, 21.
Histochemical studies have shown that, at least early in the
course of diabetic glomerulosclerosis, mesangial expansion is
due to the accumulation of proteins normally present in the
glomerulus [3], including the glycoprotein, fibronectin [4]. Sev-
eral studies have demonstrated the accumulation of fibronectin
not only in the glomerular mesangium [4], but in a variety of
other diabetic tissues, including skin [51 and blood vessels [61.
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These findings would suggest a generalized abnormality of
fibronectin metabolism in diabetes.
Plasma fibronectin is produced in the liver [7] and accumu-
lates rapidly in the normal glomerulus, where it is distributed in
a mesangial pattern [81. In addition, mesangial cells produce
fibronectin in vitro [9, 10]. Under both normal conditions and in
diabetes, it is unknown to what extent plasma fibronectin and
locally produced fibronectin contribute to the total mesangial
fibronectin. However, there is evidence that cells exposed to
the diabetic milieu in vivo [3] or exposed to high glucose
concentrations in vitro [9—11] produce excessive amounts of
fibronectin. In the present study, we evaluated the effect of high
glucose on the production of fibronectin by human glomerular
mesangial cells in culture.
Methods
Preparation and characterization of human mesangial cell
cultures
Human mesangial cells were isolated from a kidney deemed
unacceptable for transplantation according to previously de-
scribed techniques [12]. In brief, glomeruli were isolated after
passing cortical tissue through progressively smaller wire mesh
sieves (Belco, Vineland, New Jersey, USA). After exposure to
0.1% collagenase (Worthington Biochemical, Freehold, New
Jersey, USA), the glomeruli were placed in 25 cm2 plastic tissue
culture flasks (Corning, VWR, Chicago, Illinois, USA) and
cultured in tissue culture media composed of Media-l99 (con-
taining 5 mM glucose) (Gibco, Grand island, New York, USA)
supplemented with 11.5 mat Hepes (Sigma Chemical Co., St.
Louis, Missouri, USA), 26.2 mat sodium bicarbonate, 2 mM
1-glutamine (Gibco), 10% Nu-serum [containing insulin (25
gIml), selenium (20 ng/ml) and transfet-rin (50 p.g/ml)1 (Collab-
orative Research, Bedford, Massachusetts, USA), penicillin
(100 zJm1), streptomycin (100 aIml) and amphotericin-B (0.25
gIml; Gibco). After 10 to 14 days, cellular outgrowths were
evident and by 21 days the cells had attained confluency. The
cells were subsequently exposed to 0.05% trypsin in 0.53 mM
EDTA (Gibco), replated at 30 to 50% confluence and allowed to
grow to confluence. After the third passage, 3 to 6 x 106 cells
were suspended in 1 ml of complete media containing 10%
DMSO (Sigma) and stored in liquid nitrogen for later use.
Mesangial cells demonstrated characteristic stellate to fusiform
morphology [12] and were resistant to the toxic effects of
396
Nahman et al: High glucose and MC FN production 397
D-valine [131 and puromycin [14], thus excluding fibroblastic
and epithelial cell contamination, respectively. In addition,
cells demonstrated positive staining for actin, as seen in mes-
enchymal cells [121 and negative staining for factor VIII and
cytokeratin, thus excluding the presence of endothelial cells
[12] and epithelial cells [15], respectively.
Effects of glucose concentrations on mesangial cell cultures
Human mesangial cells, of passage 8 to 12, were cultured in
150 cm2 flasks (Corning) or 6, 24, or 96 well tissue culture plates
(Linbro, McLean, Virginia, USA) with media containing 5 m,
20 mii, 50 m or 115 m glucose. From these cultures, we
measured: 1) cellular proliferation; 2) fibronectin levels in the
tissue culture supernatant and matrix; 3) total protein synthesis;
and 4) fibronectin mRNA levels.
Assessment of cellular proliferation. To examine the effect of
elevated glucose levels on cellular proliferation, human mesan-
gial cells were exposed to 5 m, 20 m or 115 m glucose for
up to 14 days. Beginning at day 0, cellular proliferation was
assessed every 48 hours via direct counting (hemocytometer
counts). The effect of high glucose conditions on cell viability
was determined at the time of all hemocytometer counts by
quantitating the percent of cells excluding trypan blue. To
assess growth using an alternate method, we also examined
mesangial cell incorporation of tritiated thymidine. In these
studies, mesangial cells were incubated in 96 well plates with
media containing 5 mi, 50 mrvi or 115 m glucose for up to six
days. The cells were subsequently pulsed with 0.5 Ci tritiated
thymidine (Amersham, Arlington Heights, Illinois, USA), incu-
bated for 24 hours, washed, trypsinized and transferred to
fiberglass filters using a cell harvester (Cambridge Technology,
Cambridge, Massachusetts, USA). Radioactive counts were
determined in a scintillation counter (LKB Wallac, Turku,
Finland).
Tissue culture supernatant fibronectin concentrations. To
examine the effect of elevated glucose on tissue culture super-
natant fibronectin levels, mesangial cells were cultured in 6 well
plates with media containing 5 mM, 20 m or 115 m glucose.
All media was changed every 48 hours. On days 2, 4, 6, 8, 10,
12 and 14, direct cell counting was performed and fibronectin
levels from tissue culture supernatants were determined using
an inhibition ELISA.
To perform the fibronectin ELISA, samples of tissue culture
supernatant were diluted in 0.5 M PBS with 0.5% Tween, pH 8,
mixed with 400 jsl of 1:500 rabbit anti-fibronectin antibodies [161
and incubated for 60 minutes at 37°C. After this incubation, 100
l.d aliquots of the mixture were placed in 96 well immunoplates
(Nunc, Naperville, Illinois, USA) previously coated with 500 ng
human fibronectin (Sigma) in carbonate buffer (pH = 9.6) and
incubated at room temperature for 30 minutes. After three
washes with 0.5 M PBS-0.5% Tween, 100 sl of a peroxidase
labeled goat anti-rabbit antibody, diluted 1:2000, (Zymed, Bur-
lingame, California, USA), was added to the wells and incu-
bated for 15 minutes at room temperature. After washing, 200
p1 of o-phenylenediamine (Sigma; 0.4 mg/mI) in 25 m citric
acid buffer (pH 5) and 7 p1 of 30% H202 were added and
incubated at room temperature until wells with the strongest
color change demonstrated an optical density of 0.9 to 1 at a
wavelength of 490 nm. At this point, the reaction was arrested
with 5 M H2S04 and the optical density of each well was
determined using an automated microtiter plate reader
(Dynatech, Chantilly, Virginia, USA). The results of the assay
were compared to the mean of duplicate wells from a 10 point
standard curve constructed as described above, but substituting
known concentrations of purified human fibronectin for the
unknown samples. Because the ELISA was performed on
tissue culture supernatants containing 20 m or 115 m glucose
and 50 m glucose or 50 mri mannitol (see below), fibronectin
standard curves were constructed as above, utilizing buffers
containing 20 m'vi, 50 mvi or 115 m glucose or 50 mM mannitol.
Assessment of matrix fibronectin concentrations. To examine
the effect of elevated glucose on matrix fibronectin levels,
mesangial cells were cultured in 24 well plates in the presence of
5 mM or 20 m glucose. All media was changed every 48 hours.
On days 7 and 14, cell numbers were determined from parallel
wells and matrix fibronectin levels were determined. To remove
matrix fibronectin from the wells, cells and matrix were solu-
bilized with 1% NP-40 in PBS-Tween buffer for 10 minutes at
room temperature. The wells were then scraped with a rubber
policeman and all material subjected to sonication (30 second
pulse at 25 volts; Cole-Parmer Instrument Co., Chicago, Illi-
nois, USA). The solubilized cells and matrix were then incu-
bated at 37°C for two hours in a shaking water bath, centrifuged
at 2,000 g for 30 minutes and the supernatant frozen at —70°C
until assayed for fibronectin.
To determine matrix fibroneetin levels, the fibronectin
ELISA described above was used. Because the samples of
matrix fibronectin were solubilized in 1% NP-40, the fibronectin
standard curve was constructed using known concentrations of
purified human fibronectin dissolved in PBS-Tween buffer
containing 1% NP-40. One percent NP-40 consistently resulted
in a symmetric, downward shift of the standard curve.
Effect of osmolality on mesangial cell cultures
Because glucose changes the tonicity of media, we measured
osmolality on samples of supplemented media (freezing point
depression) and assessed the effects of of hypertonicity on
mesangial cell fibronectin production as assessed by ELISA
and Northern analysis (described below). In the former studies,
human mesangial cells were cultured in the presence of 5 m or
50 m glucose or media supplemented with 50 mrvi mannitol.
All media was changed every 48 hours. After six days in
culture, cellular proliferation (thymidine incorporation), tissue
culture supernatant and matrix fibronectin levels were deter-
mined. In addition, as an index of cell number [17], total protein
concentration (Pierce Chemical Co., Rockford, Illinois, USA)
was determined from some wells.
Assessment of mesangial cell protein synthesis by S35 incor-
poration. To investigate the effect of glucose on mesangial cell
protein synthesis, S35 labeling experiments were conducted. In
addition, to simultaneously assess cellular proliferation under
high glucose conditions, dual radioisotopic labeling, with triti-
ated thymidine, was also performed. In these experiments,
mesangial cells were incubated in 6 well plates with media
containing 5 mM, 20 m or 50 mM glucose. After seven days,
four wells from each condition were pulsed with 5 tCi of
tritiated thymidine and incubated for 24 hours. Subsequently,
the media was removed and all wells were washed with methi-
onine free media (RPMI without methionine or 1-glutamine,
Gibco) [supplemented with 25 mr'i Hepes, 10% dialyzed fetal
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calf serum (Gibco) and 2 m 1-glutamine], followed by an
incubation with 1 ml of methionine free media containing 150
Ci of S35 labeled methionine (ICN Biomedical, Irvine, Cali-
fornia, USA). After four hours at 37°C, all cells from each well
were removed with trypsin and divided into two aliquots for
scintillation counting. In one aliquot, radioactive counts result-
ing from tritiated thymidine incorporation were determined
after all DNA was transferred to fiberglass filters. In the second
aliquot, S35 emissions, resulting from the incorporation of S35
labeled methionine into newly synthesized protein, were deter-
mined after all cells were solubilized with 1% NP-40. To
minimize overlaps in the emission frequencies of tritium and
S35, the scanning windows for each radioisotope were narrowed
(using tritium and S standards) before counting labeled sam-
ples.
Assessment of mesangial cell mRNA expression by Northern
blotting and autoradiography. To determine the effect of glu-
cose on mesangial cell expression of fibronectin mRNA, mesan-
gial cells were cultured in 150 cm2 flasks with media containing
5 mM or 20 ifiM glucose or 20 m mannitol (as an osmotic
control). After two weeks, all cells were removed from the
flasks with trypsin and washed twice in M-199. Total cellular
RNA was isolated using the method of Chomczynski and
Sacchi [18]. The procedures are summarized briefly as follows:
approximately 10 million cells were homogenized with 4 M
guanidinium thiocyanate (RNAzol-B, CinnalBiotecx, Friends-
wood, Texas, USA), all protein and DNA were extracted with
acid phenol and the RNA precipitated using isopropanol. After
washing with ethanol, the samples were dried under vacuum
centrifugation and the amount of RNA was quantitated by
absorbance at 260 nm.
Ten micrograms of RNA were electrophoresed on a 1%
agarose gel in MOPS buffer (containing 0.2 M morpholinopro-
panesulfonic acid, 0.05 M sodium acetate, 0.01 M EDTA) with
0.22 M formaldehyde. For each experimental condition, equal
RNA content was confirmed by ethidium bromide staining of
the agarose gel. The RNA was transferred to a nylon membrane
(Amersham) by overnight capillary action and fixed to the
membrane by heating at 80°C for two hours.
Hybridization of the Northern blot was performed with a 1.3
kb cDNA to human fibronectin (ATCC, Rockville, Maryland,
USA) after the probe was isolated using an alkaline lysis
procedure [19], electrophoresed through a 1% agarose gel and
purified (Geneclean II, La Jolla, California, USA). The fi-
bronectin cDNA was labeled using a random priming kit
(Boehringer, Indianapolis, Indiana, USA), prehybridized for at
least three hours at 42°C in a solution containing 50% forma-
mide, 5 x SSC, 0.2% Ficoll, 0.2% polyvinypyrolidone, 0.2%
BSA, 1% SDS and 150 pg!ml herring sperm DNA. The nylon
membrane was then hybridized for 15 to 24 hours with 32P
labeled fibronectin cDNA in 50% formamide, 6x SSC, 0.5%
SDS and 150 pgJml herring sperm DNA. Subsequently, the
membrane was washed three times in 0.1 x SSC and 0.1% SDS
at 56°C and subjected to autoradiography and densitometric
analysis (LKB laser densitometer, Pharmacia LKB Biotechnol-
ogy, Inc., Piscataway, New Jersey, USA).
Statistical analysis
All data are expressed as mean standard error. Groups
were compared using an unpaired t-test or one way analysis of
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Fig. 1. Cellular proliferation as assessed by direct counting from
human mesangial cell cultures. Each bar represents the mean SEM of
3 wells for each condition. Symbols are: (0)5 m glucose; (A, D) 5 mM
glucose vs. 20 m glucose; (B, D) 5 mi glucose vs. 115 m glucose; *P
<0.05 when compared to 5 m glucose.
variance and Newman-Keuhl's test. Differences were consid-
ered significant at P values <0.05.
Results
Effect of glucose on human mesangial cell proliferation
When human mesangial cells cultured in 5 m glucose were
compared to cells cultured in 20 m glucose, 20 m glucose
resulted in a significant depression of cell numbers on day 8
(Fig. lA). This effect was more pronounced with higher con-
centrations of glucose, where 115 m glucose had a significant
effect on mesangial cell numbers as early as day 2. This effect
persisted throughout the 14 day period of study (Fig. 1B). There
was no significant effect of glucose or mannitol on cell viability
as assessed by the exclusion of trypan blue. In all experiments,
over 95% of the cells excluded the dye.
To further evaluate the effect of glucose on mesangial cell
proliferation, we investigated the effect of glucose on thymidine
incorporation by human mesangial cells. When compared to 5
m glucose, 115 m glucose significantly depressed thymidine
incorporation after 3, 4, 5 and 6 days in culture (Table 1). In
other studies, we showed that, when compared to 5 mM
A
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Table 1. Thymid
for up to 6 d
me incorporation by human mesangial cells cultured
ays in media containing 5 m or 115 m glucose
.
Days in
culture
Glucose content of media
5 mii 115 filM
3 6,453 905 2,705 149
4 11,920 583 3,851 293k
5 21,476 770 4,192 173a
6 27,417 4,017 4,002 366
glucose, 20 m glucose had no significant effect on thymidine
incorporation but that 50 m glucose and 115 m glucose
demonstrated a dose dependent inhibition in thymidine incor-
poration (percent inhibition of proliferation compared to 5 mM:
20mM, <1 4%, 50mM, 24 3% and 115 mM, 85 1%, P <
0.001 by ANOVA), suggesting that the effects of glucose on cell
proliferation are concentration dependent.
Effect of glucose on tissue culture supernatantfibronectin
concentration
Tissue culture supernatant fibronectin levels were deter-
mined from human mesangial cells cultured for up to 14 days in
5 mM, 20 m or 115 m glucose (Fig. 2). As can be seen, when
compared to 5 m glucose, cells cultured in 20 m glucose
demonstrated greater tissue culture supernatant fibronectin
levels after 8 and 10 days in culture. A similar effect was
observed from cells cultured in 115 m glucose and compared
to 5 m glucose. All tissue culture media was changed every 48
hours, thus, each data point represents total fibronectin produc-
tion for the previous 48 hours. Because total fibronectin in the
tissue culture supernatant will vary with cell number, the data
in Figure 2 are expressed as pg/cell. In addition, absolute
fibronectin levels from 20 m cells were also increased after 2,
10, 12 and 14 days in culture (that is, day 10, 5 ms, 126 6 vs.
20 mt, 136 2 sg!ml, P < 0.05).
Effect of glucose on matrix fibronectin production
Matrix fibronectin levels were determined from human
mesangial cells cultured in 5 m or 20 m glucose for 7 and 14
days. When compared to 5 m glucose, cells exposed to 20 mM
glucose for seven days demonstrated no differences in matrix
fibronectin levels (5.5 0.3 vs. 5.3 0.2 pg/cell, N = 4 wells
for each condition). In contrast, after 14 days, cells exposed to
20 mivi glucose and compared to 5 m glucose demonstrated a
significant increase in matrix fibronectin (17.2 0.2 vs. 15.1
0.3 pg/cell, N = 4 wells for each condition, P < 0.01).
Effect of osmolality on human mesangial cell cultures
Media rendered hypertonic with glucose (20 m, measured
mOsm/liter = 324) or mannitol (50 m, measured mOsm/liter =
354) demonstrated the expected rises in osmolality (calculated
mOsm/liter 323 and 354 for glucose and mannitol, respectively).
As shown in Table 2, human mesangial cells incubated for six
days in 50 m glucose demonstrated decreased proliferation, as
assessed by thymidine incorporation and total protein content
of the culture wells, when compared to 5 m glucose and 50mM
mannitol. Thus, 50 mri mannitol had no significant effect on
* *
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Table 2. Thymidine incorporation, total protein and fibronectin levels
from human mesangial cells cultured for 6 days in media containing 5
mM glucose, 50 m glucose or 50 mM mannitol
Thymidine Total Fibronectin level
incorporation protein TCS Matrix
Media cpm x IO j.g/well pg/pg TP ng/j.g TP
SmMglucose 11.4±0.3 84±8 123±17 41±11
50 m glucose 8.6 0.2a 53 2 194 15b 58 3
50 mM mannitol 11.0 0.3 89 5 184 11b 42 5
mesangial cell proliferation. In contrast, tissue culture superna-
tant fibronectin levels, when compared to 5 m glucose, were
significantly increased by both 50 m glucose and 50 mM
mannitol. Matrix fibronectin levels did not differ between these
experimental groups, an observation that is consistent with the
Values represent the mean SEM of 6 wells in counts per minute.
a P < 0.05 when compared to 5 m glucose
A
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Fig. 2. Tissue culture supernatant fibronectin levels from human
mesangial cell cultures. Each bar represents the mean SEM of 3 wells
for each culture condition. Symbols are: () 5 mM glucose; (A, 0)5mM
glucose vs. 20 m glucose; (B, 0)5 m glucose vs. 115 m glucose; *
<0.05 when compared to 5 m glucose.
Data are presented as the mean SEM of 6 wells. Abbreviation TP is
total protein.
a p < 0.05 when compared to 5 m glucose and 50 mti mannitol by
one way ANOVA
b p < 0.05 when compared to 5 m glucose (one way ANOVA)
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Table 3. Effect of glucose on proliferation and protein synthesis from
mesangial cells with dual radioisotope labels
Radioisotope incorporationa
Condition Tritiumb S35C
5 mM Glucose 10.5 0.2 1.7 0.1
20 m Glucose 9.6 0.6 1.9 0.07
50 m Glucose 9.9 0.7 2.7 0.2"
a Mean cpm x l0 SEM of 4 wells
b Tritiated thymidine incorporation as a marker of cellular prolifera-
tion
S35 methionine incorporation as a marker of protein synthesisd P < 0.001 when compared to 5 m and 20 m glucose by one way
ANOVA
data presented above, where after seven days, matrix fi-
bronectin levels were not different between mesangial cells
incubated in the presence of 5 m or 20 m glucose.
Effect of glucose on mesangial cell protein synthesis and
fibronectin mRNA expression
When the effects of glucose on protein synthesis and cellular
proliferation were simultaneously assessed by dual labeling
studies, glucose exhibited a dose dependent increase in S
incorporation and a mild decrease in thymidine uptake (Table
3). Thus, high glucose levels result in a general increase in
protein synthesis.
To specifically assess the effect of glucose on fibronectin
synthesis, mesangial cell fibronectin mRNA levels were deter-
mined from human mesangial cells cultured in the presence of 5
mM or 20 m glucose. After two weeks, and when compared to
cells cultured in media containing 5 m glucose, cells incubated
in 20 m glucose demonstrated an increase in the expression of
fibronectin mRNA, as assessed by Northern blotting and auto-
radiography (Fig. 3). A similar response was observed in cells
cultured in 20 mi mannitol (Fig. 3), suggesting that the ob-
served increase in mesangial cell fibronectin synthesis associ-
ated with elevated glucose concentrations is, at least in part, a
cellular response to increased osmolality.
Discussion
The present studies were conducted to assess the effects of
high glucose concentrations on human mesangial cell cultures.
We have shown that in the presence of high glucose, human
mesangial cells exhibit decreased proliferation and increased
production of the extracellular matrix protein, fibronectin.
The decrease in human mesangial cell proliferation associ-
ated with hypertonic glucose was not observed with similar
osmotic concentrations of mannitol, suggesting that glucose
may have a suppressive effect on mesangial cell proliferation
that is independent of osmolality. In addition, the present
results suggest that the effect of glucose on cell proliferation is
dose dependent. Thus, when compared to 20 m glucose, the
extent of mesangial cell growth suppression was more profound
with both 50 mi and 115 m glucose. The mechanisms by
which glucose inhibits cellular proliferation are unclear, how-
ever, several factors have been shown to inhibit mesangial cell
mitogenesis, including cAMP [20], atrial naturetic factor [21],
heparin [22], transforming growth factor beta (TGF/3) [23] and
prostanoids (24). The effect of glucose on these mediators is
Fig. 3. Autoradiograph of Northern blot demonstrating human mesan-
gial cell mRNA expression for fibronectin after a 2 week incubation in
media containing 5 m glucose (5G), 20 mM glucose (20G) or 20 mM
mannitol (20M). The 8.3 kb fibronectin band is indicated by the arrow.
When compared to 5 m glucose, band intensity by densitometric
analysis was enhanced by 320% and 190% for 20 m glucose and 20mM
mannitol, respectively. RNA size markers (M).
largely unknown, however TGF/3 gene expression has been
shown to be up-regulated in cultured proximal tubular cells
exposed to high glucose levels [25]. In addition, the production
of metabolic waste products unique to a high glucose environ-
ment may contribute to the observed decrease in cellular
proliferation.
In the present studies, we believe the observed increase in
fibronectin levels from high glucose cultures represents an
actual increase in fibronectin synthesis, rather than an artifact
of the methods used in their calculation (correcting the fi-
bronectin concentration for cell number, that is, fewer cells
from high glucose cultures could increase calculated fibronectin
levels). At least three lines of evidence support the contention
that the reported fibronectin levels represent an actual increase
in fibronectin synthesis: 1) when compared to 5 m glucose,
absolute fibronectin levels from 20 m cultures were increased
at several time points, despite equal or lower cell numbers; 2)
total protein synthesis, as assessed by S35 incorporation, was
increased from high glucose cultures; and 3) mRNA levels for
fibronectin were increased by 20 m glucose. In addition,
others have demonstrated an increase in fibronectin mRNA
from human endothelial [11] and rat mesangial [10] cells cul-
tured in high glucose.
The mechanisms by which elevated glucose levels may
stimulate mesangial cell fibronectin synthesis are not clear,
however, fibronectin gene expression is known to be up-
regulated by some cytokines, including epidermal growth factor
[26], gamma interferon [27], platelet-derived growth factor [26],
interleukin-6 [28] and TGFJ [23]. In addition, other factors
reported to up-regulate fibronectin mRNA include cAMP [291,
glucocorticoid [29] and vitamin D3 [30]. With the exception of
TGF3, little information is available on how glucose may
5620G20M
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modulate these factors. Of interest, the results of the present
studies demonstrate that increases in human mesangial cell
fibronectin synthesis, induced by high glucose, are also seen
with media rendered hypertonic with mannitol, suggesting that
the increase in fibronectin synthesis associated with high glu-
cose may, in part, be mediated by increased osmolality.
Fibronectin synthesis may also be regulated by feedback
inhibition through the interaction of matrix proteins with cell
surface receptors [31, 32]. Glucose may abrogate normal feed-
back mechanisms which leads to an increase in fibronectin
synthesis. This hypothesis is supported by the following obser-
vations: 1) mesangial cells cultured in wells coated with glyco-
sylated fibronectin demonstrate increased tissue culture super-
natant and matrix fibronectin [33] and 2) the observed increase
in the expression of fibronectin receptors on circulating cells
from diabetic patients [34].
The present studies utilized an in vitro model with at least
three important characteristics: First, the mesangial cells used
in these studies were derived from a single human donor, which
may limit extrapolation of these data to the population at large.
However, the identification of glucose induced up-regulation of
fibronectin gene expression by a cultured human mesangial cell
line remains an important observation demonstrating the poten-
tial biologic response of the mesangial cell to hyperglycemia.
Second, these studies utilized constant glucose and insulin
levels, which differs from patients with diabetes in whom these
levels may vary. The role of fluctuating glucose and insulin
levels in modulating mesangial cell behavior is unclear, how-
ever, it has been shown that glucose induced up-regulation of
fibronectin gene expression persists for several weeks even
after normalization of ambient glucose levels [35]. Third, the
effect of insulin on fibronectin gene expression in this model
remains to be defined. Although insulin may promote mesangial
fibronectin accumulation in rats [3], it is not known to induce
fibronectin gene expression [361.
In summary, the present studies demonstrate that, in vitro,
high glucose levels decrease human mesangial cell proliferation
and increase synthesis of the extracellular matrix protein,
fibronectin. In vivo, diabetic glomerulosclerosis is character-
ized by an accumulation of extracellular matrix protein [2],
including fibronectin [4]. The present studies suggest that
human mesangial cells may increase fibronectin synthesis in
response to hyperglycemia and that this response could con-
tribute to the accumulation of extracellular matrix common to
diabetic glomerulosclerosis.
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